Few prospective studies look at the standards of the practice of esophago-gastroduodenoscopy (EGD) and its associated morbidity.
In this study, researchers from England prospectively recorded data for 1287 consecutive day-case diagnostic EGD procedures.
After 30 days, the team successfully contacted 1155 of these patients.
|After 30 days, 10% of patients reported a problem.|
The team found that national recommendations for standard of care were met.
They found that 754 patients (70% of men and 49% of women) chose pharyngeal anesthesis (PA) as premedication. Two women had general anesthesia.
There were no immediate clinical complications. However, when the patients were contacted after 30 days, 10% reported a problem. One patient required hospital admission.
Of the patients who reported a problem, 51 of 119 had EGD performed under midazolam sedation (MS).
In addition, 25 of 119 patients required consultation with a health-care professional.
There were no deaths.
The team found that 79% of patients who underwent their procedure with PA and 95% who had MS, said they would prefer the same premedication if EGD was required in the future.
However, in subjects who had PA, 25% of women and 12% of men said they would prefer MS if EGD were required again.
Dr Syed Abbas's team concluded, "Diagnostic EGD is a safe procedure, but carries a small complication rate".
"Patients' gender, age, or patients' preference for sedation or endoscopist did not affect the morbidity rate".
"Although the majority, particularly men, chose to have EGD performed unsedated, a significant number, particularly women, would prefer MS if EGD was required again".